Your browser doesn't support javascript.
loading
GRK2 kinases in the primary cilium initiate SMOOTHENED-PKA signaling in the Hedgehog cascade.
Walker, Madison F; Zhang, Jingyi; Steiner, William; Ku, Pei-I; Zhu, Ju-Fen; Michaelson, Zachary; Yen, Yu-Chen; Lee, Annabel; Long, Alyssa B; Casey, Mattie J; Poddar, Abhishek; Nelson, Isaac B; Arveseth, Corvin D; Nagel, Falko; Clough, Ryan; LaPotin, Sarah; Kwan, Kristen M; Schulz, Stefan; Stewart, Rodney A; Tesmer, John J G; Caspary, Tamara; Subramanian, Radhika; Ge, Xuecai; Myers, Benjamin R.
  • Walker MF; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Zhang J; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Steiner W; Department of Bioengineering, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Ku PI; Department of Molecular and Cell Biology, School of Natural Sciences, University of California, Merced, California, United States of America.
  • Zhu JF; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Michaelson Z; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Yen YC; Department of Bioengineering, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Lee A; Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Long AB; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Casey MJ; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Poddar A; Department of Bioengineering, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Nelson IB; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Arveseth CD; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Nagel F; Department of Bioengineering, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Clough R; Department of Biological Sciences, Purdue University, West Lafayette, Indiana, United States of America.
  • LaPotin S; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Kwan KM; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Schulz S; Department of Bioengineering, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Stewart RA; Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia, United States of America.
  • Tesmer JJG; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Caspary T; Department of Molecular Biology, Massachusetts General Hospital, Boston, Massachusetts, USA; Department of Genetics, Harvard Medical School, Boston, Massachusetts, United States of America.
  • Subramanian R; Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Ge X; Department of Biochemistry, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
  • Myers BR; Department of Bioengineering, University of Utah School of Medicine, Salt Lake City, Utah, United States of America.
PLoS Biol ; 22(8): e3002685, 2024 Aug.
Article en En | MEDLINE | ID: mdl-39138140
ABSTRACT
During Hedgehog (Hh) signal transduction in development and disease, the atypical G protein-coupled receptor (GPCR) SMOOTHENED (SMO) communicates with GLI transcription factors by binding the protein kinase A catalytic subunit (PKA-C) and physically blocking its enzymatic activity. Here, we show that GPCR kinase 2 (GRK2) orchestrates this process during endogenous mouse and zebrafish Hh pathway activation in the primary cilium. Upon SMO activation, GRK2 rapidly relocalizes from the ciliary base to the shaft, triggering SMO phosphorylation and PKA-C interaction. Reconstitution studies reveal that GRK2 phosphorylation enables active SMO to bind PKA-C directly. Lastly, the SMO-GRK2-PKA pathway underlies Hh signal transduction in a range of cellular and in vivo models. Thus, GRK2 phosphorylation of ciliary SMO and the ensuing PKA-C binding and inactivation are critical initiating events for the intracellular steps in Hh signaling. More broadly, our study suggests an expanded role for GRKs in enabling direct GPCR interactions with diverse intracellular effectors.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pez Cebra / Transducción de Señal / Cilios / Proteínas Quinasas Dependientes de AMP Cíclico / Proteínas Hedgehog / Quinasa 2 del Receptor Acoplado a Proteína-G / Receptor Smoothened Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pez Cebra / Transducción de Señal / Cilios / Proteínas Quinasas Dependientes de AMP Cíclico / Proteínas Hedgehog / Quinasa 2 del Receptor Acoplado a Proteína-G / Receptor Smoothened Límite: Animals Idioma: En Año: 2024 Tipo del documento: Article